Literature DB >> 29063416

Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis.

Hyo-Joon Yang1, Yoosoo Chang2,3,4, Soo-Kyung Park1, Yoon Suk Jung1, Jung Ho Park1, Dong Il Park1, Yong Kyun Cho1, Seungho Ryu5,6,7, Chong Il Sohn8.   

Abstract

BACKGROUND: Reflux esophagitis is associated with obesity and metabolic syndrome; however, the relationship between nonalcoholic fatty liver disease (NAFLD) and reflux esophagitis is unclear. AIM: We examined the association between NAFLD and the development of reflux esophagitis.
METHODS: Our cohort consisted of 117,377 Korean adults without reflux esophagitis at baseline who underwent a health checkup program including upper endoscopy between 2002 and 2014 and were followed annually or biennially until December 2014. NAFLD was defined as hepatic steatosis on ultrasonography in the absence of excessive alcohol use or any other identifiable cause.
RESULTS: Over 520,843.2 person-years of follow-up, 22,500 participants developed reflux esophagitis (incidence density, 43.2 per 1000 person-years). In models adjusted for age and sex, the adjusted hazard ratio (aHR) (95% confidence interval [CI]) for incident reflux esophagitis in subjects with NAFLD compared to those without was 1.16 (1.13-1.20). After further adjustment for confounders of center, year of visit, smoking status, alcohol intake, regular exercise, education level, and body mass index, the association between NAFLD and incident reflux esophagitis was attenuated, but remained significant (aHR 1.06; 95% CI 1.02-1.10).
CONCLUSIONS: In this large cohort of Korean men and women, participants with NAFLD exhibited increased incidence of reflux esophagitis independent of possible confounders, suggesting that NAFLD contributes to the development of reflux esophagitis.

Entities:  

Keywords:  Cohort studies; Esophagitis, peptic; Gastroesophageal reflux; Gastroscopy; Nonalcoholic fatty liver disease; Risk factors

Mesh:

Year:  2017        PMID: 29063416     DOI: 10.1007/s10620-017-4805-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  51 in total

1.  Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.

Authors:  Patrick Royston; Mahesh K B Parmar
Journal:  Stat Med       Date:  2002-08-15       Impact factor: 2.373

2.  Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader; Gianfranco Pagano
Journal:  Ann Med       Date:  2010-11-02       Impact factor: 4.709

3.  Nonalcoholic fatty liver disease increases risk for gastroesophageal reflux symptoms.

Authors:  Roberto Catanzaro; Federica Calabrese; Sergio Occhipinti; Maria Grazia Anzalone; Angelo Italia; Michele Milazzo; Francesco Marotta
Journal:  Dig Dis Sci       Date:  2014-04-10       Impact factor: 3.199

4.  Nonalcoholic fatty liver disease vs. obesity on the risk of erosive oesophagitis.

Authors:  Wei-Chieh Hung; Jin-Shang Wu; Yi-Ching Yang; Zih-Jie Sun; Feng-Hwa Lu; Chih-Jen Chang
Journal:  Eur J Clin Invest       Date:  2014-11-03       Impact factor: 4.686

5.  Associations between different forms of gastro-oesophageal reflux disease.

Authors:  H B el-Serag; A Sonnenberg
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

6.  Gastroesophageal reflux induced by exercise in healthy volunteers.

Authors:  C S Clark; B B Kraus; J Sinclair; D O Castell
Journal:  JAMA       Date:  1989 Jun 23-30       Impact factor: 56.272

Review 7.  Nonalcoholic fatty liver disease as a multi-systemic disease.

Authors:  Hakan Fotbolcu; Elçin Zorlu
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

Review 8.  [Endoscopic findings of GERD].

Authors:  Yoshio Hoshihara
Journal:  Nihon Rinsho       Date:  2004-08

9.  Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study.

Authors:  Yiyi Zhang; Yoosoo Chang; Seungho Ryu; Juhee Cho; Won-Young Lee; Eun-Jung Rhee; Min-Jung Kwon; Roberto Pastor-Barriuso; Sanjay Rampal; Won Kon Han; Hocheol Shin; Eliseo Guallar
Journal:  Int J Epidemiol       Date:  2014-10       Impact factor: 7.196

10.  Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study.

Authors:  Hyeon Chang Kim; Chung Mo Nam; Sun Ha Jee; Kwang Hyub Han; Dae Kyu Oh; Il Suh
Journal:  BMJ       Date:  2004-03-17
View more
  2 in total

1.  Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms.

Authors:  Yuan He; Zhi-Jun Duan; Cheng-Fang Wang; Yu-Shan Wei; Ming-Xu Cai
Journal:  Diabetes Metab Syndr Obes       Date:  2022-01-20       Impact factor: 3.168

2.  Safety and Effectiveness of Essential Phospholipids Paste in Patients with Non-alcoholic Fatty Liver Disease or Viral Hepatitis.

Authors:  Vladimir T Ivashkin; Igor V Maev; Chavdar S Pavlov; Marina V Mayevskaya; Aleksey A Samsonov; Lyudmila K Palgova; Kirill M Starostin
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.